Anthropic Says Claude Found Something Big in DNA. It Just Doesn't Know What

What happened

Anthropic says its Claude tool autonomously found a new CRISPR-like enzyme system. The article reports that even Dario Amodei admits nobody knows what the system actually does.

Confirmed

Global impact / market context

If Claude can autonomously find a new CRISPR-like enzyme system, that suggests AI may help biotech companies discover gene-editing tools faster. Because the enzyme's function is unknown, no revenue or product can yet be tied to it.

Analyst inference

Gene-editing research is costly and slow, so any tool that shortens discovery time matters for biotech companies. Because the enzyme's purpose is unknown, investors cannot yet connect it to treatments, revenue, or costs.

Analyst inference

What to watch

1. Watch whether Anthropic publishes more detail on how Claude found the new CRISPR-like enzyme system, since the article gives no method or data. Confirmed
2. Watch for any statement from Dario Amodei or Anthropic clarifying what the discovered CRISPR-like enzyme system does, because the article says its function is unknown. Proposed
3. Watch whether biotech companies announce research partnerships or new spending on AI discovery tools, which would show real commercial interest in Claude's enzyme finding. Analyst inference

Evidence

• decrypt.co